Based on conformational analysis and GRID-contour calculations we deve
loped a common primary pharmacophore for rolipram analog, nitraquazone
and xanthine derivative PDE IV inhibitors. In spite of the structural
differences exhibited by the three substance classes we could provide
evidence that they share common hydrogen bonding and lipophilic enzym
e binding sites.